EGFR and neoplasm: Sera possessing anti-EGFR-derived-peptide IgGs also failed to show either direct growth inhibition of tumour cells in vitro or to elicit antibody-dependent cell-mediated cytotoxicity to tumour cells to the degree that they have been tested.